相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Stem-cell therapy for cardiac disease
Vincent F. M. Segers et al.
NATURE (2008)
Fibroblast growth factor-2 regulates myocardial infarct repair - Effects on cell proliferation, scar contraction, and ventricular function
Jitka A. I. Virag et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways
Sandra B. Haudek et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The role of TGF-β signaling in myocardial infarction and cardiac remodeling
Marcin Bujak et al.
CARDIOVASCULAR RESEARCH (2007)
Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines
Shafie Fazel et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Intracoronary bone marrow cell transfer after myocardial infarction - Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial
GP Meyer et al.
CIRCULATION (2006)
The dying stem cell hypothesis - Immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle
T Thum et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Cell transplantation preserves cardiac function after infarction by infarct stabilization: Augmentation by stem cell factor
S Fazel et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2005)
Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes
RD Stout et al.
IMMUNOLOGICAL REVIEWS (2005)
Current status of cellular therapy for ischemic heart disease
S Fazel et al.
ANNALS OF THORACIC SURGERY (2005)
CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts
O Dewald et al.
CIRCULATION RESEARCH (2005)
Inhibition of TGF-β signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction
M Ikeuchi et al.
CARDIOVASCULAR RESEARCH (2004)
Excessive tumor necrosis factor activation after infarction contributes to susceptibility of myocardial rupture and left ventricular dysfunction
M Sun et al.
CIRCULATION (2004)
Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-α, in patients with moderate-to-severe heart failure -: Results of the Anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial
ES Chung et al.
CIRCULATION (2003)
Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair
JI Virag et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Myofibroblasts and mechano-regulation of connective tissue remodelling
JJ Tomasek et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)